ID   ACES_TORCA              Reviewed;         586 AA.
AC   P04058;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   22-JUL-2015, entry version 139.
DE   RecName: Full=Acetylcholinesterase;
DE            Short=AChE;
DE            EC=3.1.1.7;
DE   Flags: Precursor;
GN   Name=ache;
OS   Torpedo californica (Pacific electric ray).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes;
OC   Elasmobranchii; Batoidea; Torpediniformes; Torpedinidae; Torpedo.
OX   NCBI_TaxID=7787;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-586.
RX   PubMed=3753747; DOI=10.1038/319407a0;
RA   Schumacher M., Camp S., Maulet Y., Newton M., McPhee-Quigley K.,
RA   Taylor S.S., Friedmann T., Taylor P.;
RT   "Primary structure of Torpedo californica acetylcholinesterase deduced
RT   from its cDNA sequence.";
RL   Nature 319:407-409(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RX   PubMed=3198606;
RA   Schumacher M.;
RT   "Multiple messenger RNA species give rise to the structural diversity
RT   in acetylcholinesterase.";
RL   J. Biol. Chem. 263:18979-18987(1988).
RN   [3]
RP   PROTEIN SEQUENCE OF 22-45 AND 214-237.
RX   PubMed=3900071;
RA   MacPhee-Quigley K., Taylor P., Taylor S.;
RT   "Primary structures of the catalytic subunits from two molecular forms
RT   of acetylcholinesterase. A comparison of NH2-terminal and active
RT   center sequences.";
RL   J. Biol. Chem. 260:12185-12189(1985).
RN   [4]
RP   PROTEIN SEQUENCE OF 100-108.
RX   PubMed=2068091; DOI=10.1073/pnas.88.14.6117;
RA   Kreienkamp H.J., Weise C., Raba R., Aaviksaar A., Hucho F.;
RT   "Anionic subsites of the catalytic center of acetylcholinesterase from
RT   Torpedo and from cobra venom.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:6117-6121(1991).
RN   [5]
RP   PROTEIN SEQUENCE OF 552-558.
RX   PubMed=3335534;
RA   Gibney G., Macphee-Quigley K., Thompson B., Vedvick T., Low M.G.,
RA   Taylor S.S., Taylor P.;
RT   "Divergence in primary structure between the molecular forms of
RT   acetylcholinesterase.";
RL   J. Biol. Chem. 263:1140-1145(1988).
RN   [6]
RP   ALTERNATIVE SPLICING.
RX   PubMed=2306366; DOI=10.1016/0896-6273(90)90103-M;
RA   Maulet Y., Camp S., Gibney G., Rachinsky T.L., Ekstroem T.J.,
RA   Taylor P.;
RT   "Single gene encodes glycophospholipid-anchored and asymmetric
RT   acetylcholinesterase forms: alternative coding exons contain inverted
RT   repeat sequences.";
RL   Neuron 4:289-301(1990).
RN   [7]
RP   DISULFIDE BONDS.
RX   PubMed=3759980;
RA   McPhee-Quigley K., Vedvick T.S., Taylor P., Taylor S.S.;
RT   "Profile of the disulfide bonds in acetylcholinesterase.";
RL   J. Biol. Chem. 261:13565-13570(1986).
RN   [8]
RP   STRUCTURE OF THE GPI-ANCHOR.
RX   PubMed=8257440;
RA   Mehlert A., Varon L., Silman I., Homans S.W., Ferguson M.A.;
RT   "Structure of the glycosyl-phosphatidylinositol membrane anchor of
RT   acetylcholinesterase from the electric organ of the electric-fish,
RT   Torpedo californica.";
RL   Biochem. J. 296:473-479(1993).
RN   [9]
RP   GPI-ANCHOR AT SER-564.
RX   PubMed=8597567; DOI=10.1016/0167-4838(95)00205-7;
RA   Bucht G., Hjalmarsson K.;
RT   "Residues in Torpedo californica acetylcholinesterase necessary for
RT   processing to a glycosyl phosphatidylinositol-anchored form.";
RL   Biochim. Biophys. Acta 1292:223-232(1996).
RN   [10]
RP   MUTAGENESIS.
RX   PubMed=2217185; DOI=10.1073/pnas.87.19.7546;
RA   Gibney G., Camp S., Dionne M., McPhee-Quigley K., Taylor P.;
RT   "Mutagenesis of essential functional residues in
RT   acetylcholinesterase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7546-7550(1990).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 22-558, ACTIVE SITE,
RP   GLYCOSYLATION AT ASN-437, DISULFIDE BONDS, AND SUBUNIT.
RX   PubMed=1678899; DOI=10.1126/science.1678899;
RA   Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L.,
RA   Silman I.;
RT   "Atomic structure of acetylcholinesterase from Torpedo californica: a
RT   prototypic acetylcholine-binding protein.";
RL   Science 253:872-879(1991).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 22-556 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS.
RX   PubMed=8415649; DOI=10.1073/pnas.90.19.9031;
RA   Harel M., Schalk I., Ehret-Sabatier L., Bouet F., Goeldner M.,
RA   Hirth C., Axelsen P.H., Silman I., Sussman J.L.;
RT   "Quaternary ligand binding to aromatic residues in the active-site
RT   gorge of acetylcholinesterase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:9031-9035(1993).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 22-558 IN COMPLEX WITH
RP   FASCICULIN-2, AND DISULFIDE BOND.
RX   PubMed=8747462; DOI=10.1016/S0969-2126(01)00273-8;
RA   Harel M., Kleywegt G.J., Ravelli R.B., Silman I., Sussman J.L.;
RT   "Crystal structure of an acetylcholinesterase-fasciculin complex:
RT   interaction of a three-fingered toxin from snake venom with its
RT   target.";
RL   Structure 3:1355-1366(1995).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 22-558 IN COMPLEX WITH THE
RP   INHIBITOR HUPERZINE A.
RX   PubMed=8989325; DOI=10.1038/nsb0197-57;
RA   Raves M.L., Harel M., Pang Y.P., Silman I., Kozikowski A.P.,
RA   Sussman J.L.;
RT   "Structure of acetylcholinesterase complexed with the nootropic
RT   alkaloid, (-)-huperzine A.";
RL   Nat. Struct. Biol. 4:57-63(1997).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 22-558.
RX   PubMed=10231521; DOI=10.1021/bi982723p;
RA   Bartolucci C., Perola E., Cellai L., Brufani M., Lamba D.;
RT   "'Back door' opening implied by the crystal structure of a
RT   carbamoylated acetylcholinesterase.";
RL   Biochemistry 38:5714-5719(1999).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 22-558.
RX   PubMed=10353814; DOI=10.1021/bi982678l;
RA   Millard C.B., Kryger G., Ordentlich A., Greenblatt H.M., Harel M.,
RA   Raves M.L., Segall Y., Barak D., Shafferman A., Silman I.,
RA   Sussman J.L.;
RT   "Crystal structures of aged phosphonylated acetylcholinesterase: nerve
RT   agent reaction products at the atomic level.";
RL   Biochemistry 38:7032-7039(1999).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 22-564 IN COMPLEX WITH
RP   GALANTHAMINE.
RX   PubMed=10606746; DOI=10.1016/S0014-5793(99)01637-3;
RA   Greenblatt H.M., Kryger G., Lewis T., Silman I., Sussman J.L.;
RT   "Structure of acetylcholinesterase complexed with (-)-galanthamine at
RT   2.3-A resolution.";
RL   FEBS Lett. 463:321-326(1999).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 22-564 IN COMPLEX WITH THE
RP   SYNTHETIC INHIBITOR ARICEPT, AND GLYCOSYLATION AT ASN-80; ASN-437;
RP   ASN-478 AND ASN-554.
RX   PubMed=10368299; DOI=10.1016/S0969-2126(99)80040-9;
RA   Kryger G., Silman I., Sussman J.L.;
RT   "Structure of acetylcholinesterase complexed with E2020 (Aricept(R)):
RT   implications for the design of new anti-Alzheimer drugs.";
RL   Structure 7:297-307(1999).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 22-564 IN COMPLEX WITH THE
RP   SYNTHETIC INHIBITOR HUPRINE.
RX   PubMed=11863435; DOI=10.1021/bi011652i;
RA   Dvir H., Wong D.M., Harel M., Barril X., Orozco M., Luque F.J.,
RA   Munoz-Torrero D., Camps P., Rosenberry T.L., Silman I., Sussman J.L.;
RT   "3D structure of Torpedo californica acetylcholinesterase complexed
RT   with huprine X at 2.1 A resolution: kinetic and molecular dynamic
RT   correlates.";
RL   Biochemistry 41:2970-2981(2002).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 25-556 IN COMPLEX WITH THE
RP   SYNTHETIC INHIBITOR RIVASTIGMINE.
RX   PubMed=11888271; DOI=10.1021/bi020016x;
RA   Bar-On P., Millard C.B., Harel M., Dvir H., Enz A., Sussman J.L.,
RA   Silman I.;
RT   "Kinetic and structural studies on the interaction of cholinesterases
RT   with the anti-Alzheimer drug rivastigmine.";
RL   Biochemistry 41:3555-3564(2002).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 22-564 IN COMPLEX WITH THE
RP   SYNTHETIC INHIBITOR CPT-11.
RX   PubMed=15772291; DOI=10.1124/mol.104.009944;
RA   Harel M., Hyatt J.L., Brumshtein B., Morton C.L., Yoon K.J.,
RA   Wadkins R.M., Silman I., Sussman J.L., Potter P.M.;
RT   "The crystal structure of the complex of the anticancer prodrug 7-
RT   ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-
RT   11) with Torpedo californica acetylcholinesterase provides a molecular
RT   explanation for its cholinergic action.";
RL   Mol. Pharmacol. 67:1874-1881(2005).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 22-558 IN COMPLEXES WITH
RP   SUBSTRATE AND SUBSTRATE ANALOGS, GLYCOSYLATION AT ASN-80 AND ASN-437,
RP   ACTIVE SITE, AND ENZYME REGULATION.
RX   PubMed=16763558; DOI=10.1038/sj.emboj.7601175;
RA   Colletier J.-P., Fournier D., Greenblatt H.M., Stojan J.,
RA   Sussman J.L., Zaccai G., Silman I., Weik M.;
RT   "Structural insights into substrate traffic and inhibition in
RT   acetylcholinesterase.";
RL   EMBO J. 25:2746-2756(2006).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 22-558 IN COMPLEX WITH SOMAN,
RP   ACTIVE SITE, AND DISULFIDE BONDS.
RX   PubMed=19642642; DOI=10.1021/jm900433t;
RA   Sanson B., Nachon F., Colletier J.P., Froment M.T., Toker L.,
RA   Greenblatt H.M., Sussman J.L., Ashani Y., Masson P., Silman I.,
RA   Weik M.;
RT   "Crystallographic snapshots of nonaged and aged conjugates of soman
RT   with acetylcholinesterase, and of a ternary complex of the aged
RT   conjugate with pralidoxime.";
RL   J. Med. Chem. 52:7593-7603(2009).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 23-556 IN COMPLEX WITH
RP   GALANTHAMINE DERIVATIVES.
RX   PubMed=20025280; DOI=10.1021/jm901296p;
RA   Bartolucci C., Haller L.A., Jordis U., Fels G., Lamba D.;
RT   "Probing Torpedo californica acetylcholinesterase catalytic gorge with
RT   two novel bis-functional galanthamine derivatives.";
RL   J. Med. Chem. 53:745-751(2010).
CC   -!- FUNCTION: Terminates signal transduction at the neuromuscular
CC       junction by rapid hydrolysis of the acetylcholine released into
CC       the synaptic cleft. May be involved in cell-cell interactions.
CC   -!- CATALYTIC ACTIVITY: Acetylcholine + H(2)O = choline + acetate.
CC   -!- ENZYME REGULATION: Inhibited by substrate concentrations above 0.5
CC       mM. {ECO:0000269|PubMed:16763558}.
CC   -!- SUBUNIT: Isoform H form is a homodimer; the asymmetric form is a
CC       disulfide-bonded oligomer composed of a collagenic subunit (Q) and
CC       a variable number of T catalytic subunits.
CC       {ECO:0000269|PubMed:10368299, ECO:0000269|PubMed:10606746,
CC       ECO:0000269|PubMed:11863435, ECO:0000269|PubMed:11888271,
CC       ECO:0000269|PubMed:15772291, ECO:0000269|PubMed:1678899,
CC       ECO:0000269|PubMed:19642642, ECO:0000269|PubMed:20025280,
CC       ECO:0000269|PubMed:8415649, ECO:0000269|PubMed:8747462,
CC       ECO:0000269|PubMed:8989325}.
CC   -!- SUBCELLULAR LOCATION: Isoform H: Cell membrane; Lipid-anchor, GPI-
CC       anchor. Cell junction, synapse.
CC   -!- SUBCELLULAR LOCATION: Isoform T: Cell membrane; Peripheral
CC       membrane protein. Cell junction, synapse. Note=Attached to the
CC       membrane through disulfide linkage with the collagenic subunit,
CC       itself bound to the membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=H; Synonyms=Globular;
CC         IsoId=P04058-1; Sequence=Displayed;
CC         Note=GPI-anchored form.;
CC       Name=T;
CC         IsoId=P04058-2; Sequence=VSP_001460;
CC   -!- TISSUE SPECIFICITY: Found in the synapses and to a lower extent in
CC       extrajunctional areas of muscle and nerve, and on erythrocyte
CC       membranes.
CC   -!- PTM: An interchain disulfide bond is present in what becomes
CC       position 593 of the T isoform.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03439; CAA27169.1; -; mRNA.
DR   EMBL; X56516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X56517; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A00773; ACRYE.
DR   PDB; 1ACJ; X-ray; 2.80 A; A=22-556.
DR   PDB; 1ACL; X-ray; 2.80 A; A=22-556.
DR   PDB; 1AMN; X-ray; 2.80 A; A=22-558.
DR   PDB; 1AX9; X-ray; 2.80 A; A=22-558.
DR   PDB; 1CFJ; X-ray; 2.60 A; A=22-558.
DR   PDB; 1DX6; X-ray; 2.30 A; A=22-564.
DR   PDB; 1E3Q; X-ray; 2.85 A; A=22-564.
DR   PDB; 1E66; X-ray; 2.10 A; A=22-564.
DR   PDB; 1EA5; X-ray; 1.80 A; A=22-558.
DR   PDB; 1EEA; X-ray; 4.50 A; A=22-555.
DR   PDB; 1EVE; X-ray; 2.50 A; A=22-564.
DR   PDB; 1FSS; X-ray; 3.00 A; A=22-558.
DR   PDB; 1GPK; X-ray; 2.10 A; A=22-558.
DR   PDB; 1GPN; X-ray; 2.35 A; A=22-558.
DR   PDB; 1GQR; X-ray; 2.20 A; A=25-556.
DR   PDB; 1GQS; X-ray; 3.00 A; A=25-556.
DR   PDB; 1H22; X-ray; 2.15 A; A=22-564.
DR   PDB; 1H23; X-ray; 2.15 A; A=22-564.
DR   PDB; 1HBJ; X-ray; 2.50 A; A=22-564.
DR   PDB; 1JGA; Model; -; A=1-586.
DR   PDB; 1JGB; Model; -; A=1-586.
DR   PDB; 1JJB; X-ray; 2.30 A; A=25-556.
DR   PDB; 1OCE; X-ray; 2.70 A; A=22-558.
DR   PDB; 1ODC; X-ray; 2.20 A; A=22-564.
DR   PDB; 1QID; X-ray; 2.05 A; A=22-558.
DR   PDB; 1QIE; X-ray; 2.10 A; A=22-558.
DR   PDB; 1QIF; X-ray; 2.10 A; A=22-558.
DR   PDB; 1QIG; X-ray; 2.30 A; A=22-558.
DR   PDB; 1QIH; X-ray; 2.50 A; A=22-558.
DR   PDB; 1QII; X-ray; 2.65 A; A=22-558.
DR   PDB; 1QIJ; X-ray; 2.80 A; A=22-558.
DR   PDB; 1QIK; X-ray; 2.90 A; A=22-558.
DR   PDB; 1QIM; X-ray; 3.00 A; A=22-558.
DR   PDB; 1QTI; X-ray; 2.50 A; A=22-558.
DR   PDB; 1SOM; X-ray; 2.20 A; A=22-564.
DR   PDB; 1U65; X-ray; 2.61 A; A=22-564.
DR   PDB; 1UT6; X-ray; 2.40 A; A=22-556.
DR   PDB; 1VOT; X-ray; 2.50 A; A=22-558.
DR   PDB; 1VXO; X-ray; 2.40 A; A=22-558.
DR   PDB; 1VXR; X-ray; 2.20 A; A=22-558.
DR   PDB; 1W4L; X-ray; 2.16 A; A=22-564.
DR   PDB; 1W6R; X-ray; 2.05 A; A=22-564.
DR   PDB; 1W75; X-ray; 2.40 A; A/B=22-564.
DR   PDB; 1W76; X-ray; 2.30 A; A/B=22-564.
DR   PDB; 1ZGB; X-ray; 2.30 A; A=22-564.
DR   PDB; 1ZGC; X-ray; 2.10 A; A/B=22-564.
DR   PDB; 2ACE; X-ray; 2.50 A; A=22-558.
DR   PDB; 2ACK; X-ray; 2.40 A; A=22-558.
DR   PDB; 2BAG; X-ray; 2.40 A; A=22-564.
DR   PDB; 2C4H; X-ray; 2.15 A; A=22-558.
DR   PDB; 2C58; X-ray; 2.30 A; A=22-558.
DR   PDB; 2C5F; X-ray; 2.60 A; A=22-558.
DR   PDB; 2C5G; X-ray; 1.95 A; A=22-558.
DR   PDB; 2CEK; X-ray; 2.20 A; A=22-556.
DR   PDB; 2CKM; X-ray; 2.15 A; A=22-564.
DR   PDB; 2CMF; X-ray; 2.50 A; A=22-564.
DR   PDB; 2DFP; X-ray; 2.30 A; A=23-556.
DR   PDB; 2J3D; X-ray; 2.60 A; A=22-564.
DR   PDB; 2J3Q; X-ray; 2.80 A; A=22-564.
DR   PDB; 2J4F; X-ray; 2.80 A; A=22-564.
DR   PDB; 2V96; X-ray; 2.40 A; A/B=22-558.
DR   PDB; 2V97; X-ray; 2.40 A; A/B=22-558.
DR   PDB; 2V98; X-ray; 3.00 A; A/B=22-558.
DR   PDB; 2VA9; X-ray; 2.40 A; A/B=22-558.
DR   PDB; 2VJA; X-ray; 2.30 A; A/B=22-558.
DR   PDB; 2VJB; X-ray; 2.39 A; A/B=22-558.
DR   PDB; 2VJC; X-ray; 2.20 A; A/B=22-558.
DR   PDB; 2VJD; X-ray; 2.30 A; A/B=22-558.
DR   PDB; 2VQ6; X-ray; 2.71 A; A=22-564.
DR   PDB; 2VT6; X-ray; 2.40 A; A/B=22-558.
DR   PDB; 2VT7; X-ray; 2.20 A; A/B=22-558.
DR   PDB; 2W6C; X-ray; 2.69 A; X=1-586.
DR   PDB; 2W9I; X-ray; 2.43 A; A=1-586.
DR   PDB; 2WFZ; X-ray; 1.95 A; A=22-558.
DR   PDB; 2WG0; X-ray; 2.20 A; A=22-558.
DR   PDB; 2WG1; X-ray; 2.20 A; A=22-558.
DR   PDB; 2WG2; X-ray; 1.95 A; A=22-558.
DR   PDB; 2XI4; X-ray; 2.30 A; A/B=22-558.
DR   PDB; 3ACE; Model; -; A=22-558.
DR   PDB; 3GEL; X-ray; 2.39 A; A=25-556.
DR   PDB; 3I6M; X-ray; 2.26 A; A=23-556.
DR   PDB; 3I6Z; X-ray; 2.19 A; A=23-556.
DR   PDB; 3M3D; X-ray; 2.34 A; A=22-564.
DR   PDB; 3ZV7; X-ray; 2.26 A; A=22-564.
DR   PDB; 4ACE; Model; -; A=22-558.
DR   PDB; 4TVK; X-ray; 2.30 A; A=23-556.
DR   PDBsum; 1ACJ; -.
DR   PDBsum; 1ACL; -.
DR   PDBsum; 1AMN; -.
DR   PDBsum; 1AX9; -.
DR   PDBsum; 1CFJ; -.
DR   PDBsum; 1DX6; -.
DR   PDBsum; 1E3Q; -.
DR   PDBsum; 1E66; -.
DR   PDBsum; 1EA5; -.
DR   PDBsum; 1EEA; -.
DR   PDBsum; 1EVE; -.
DR   PDBsum; 1FSS; -.
DR   PDBsum; 1GPK; -.
DR   PDBsum; 1GPN; -.
DR   PDBsum; 1GQR; -.
DR   PDBsum; 1GQS; -.
DR   PDBsum; 1H22; -.
DR   PDBsum; 1H23; -.
DR   PDBsum; 1HBJ; -.
DR   PDBsum; 1JGA; -.
DR   PDBsum; 1JGB; -.
DR   PDBsum; 1JJB; -.
DR   PDBsum; 1OCE; -.
DR   PDBsum; 1ODC; -.
DR   PDBsum; 1QID; -.
DR   PDBsum; 1QIE; -.
DR   PDBsum; 1QIF; -.
DR   PDBsum; 1QIG; -.
DR   PDBsum; 1QIH; -.
DR   PDBsum; 1QII; -.
DR   PDBsum; 1QIJ; -.
DR   PDBsum; 1QIK; -.
DR   PDBsum; 1QIM; -.
DR   PDBsum; 1QTI; -.
DR   PDBsum; 1SOM; -.
DR   PDBsum; 1U65; -.
DR   PDBsum; 1UT6; -.
DR   PDBsum; 1VOT; -.
DR   PDBsum; 1VXO; -.
DR   PDBsum; 1VXR; -.
DR   PDBsum; 1W4L; -.
DR   PDBsum; 1W6R; -.
DR   PDBsum; 1W75; -.
DR   PDBsum; 1W76; -.
DR   PDBsum; 1ZGB; -.
DR   PDBsum; 1ZGC; -.
DR   PDBsum; 2ACE; -.
DR   PDBsum; 2ACK; -.
DR   PDBsum; 2BAG; -.
DR   PDBsum; 2C4H; -.
DR   PDBsum; 2C58; -.
DR   PDBsum; 2C5F; -.
DR   PDBsum; 2C5G; -.
DR   PDBsum; 2CEK; -.
DR   PDBsum; 2CKM; -.
DR   PDBsum; 2CMF; -.
DR   PDBsum; 2DFP; -.
DR   PDBsum; 2J3D; -.
DR   PDBsum; 2J3Q; -.
DR   PDBsum; 2J4F; -.
DR   PDBsum; 2V96; -.
DR   PDBsum; 2V97; -.
DR   PDBsum; 2V98; -.
DR   PDBsum; 2VA9; -.
DR   PDBsum; 2VJA; -.
DR   PDBsum; 2VJB; -.
DR   PDBsum; 2VJC; -.
DR   PDBsum; 2VJD; -.
DR   PDBsum; 2VQ6; -.
DR   PDBsum; 2VT6; -.
DR   PDBsum; 2VT7; -.
DR   PDBsum; 2W6C; -.
DR   PDBsum; 2W9I; -.
DR   PDBsum; 2WFZ; -.
DR   PDBsum; 2WG0; -.
DR   PDBsum; 2WG1; -.
DR   PDBsum; 2WG2; -.
DR   PDBsum; 2XI4; -.
DR   PDBsum; 3ACE; -.
DR   PDBsum; 3GEL; -.
DR   PDBsum; 3I6M; -.
DR   PDBsum; 3I6Z; -.
DR   PDBsum; 3M3D; -.
DR   PDBsum; 3ZV7; -.
DR   PDBsum; 4ACE; -.
DR   PDBsum; 4TVK; -.
DR   ProteinModelPortal; P04058; -.
DR   SMR; P04058; 23-556.
DR   MINT; MINT-1518870; -.
DR   BindingDB; P04058; -.
DR   ChEMBL; CHEMBL4780; -.
DR   ESTHER; torca-ACHE; AChE.
DR   MEROPS; S09.980; -.
DR   HOVERGEN; HBG008839; -.
DR   BioCyc; MetaCyc:MONOMER-16823; -.
DR   BRENDA; 3.1.1.7; 6395.
DR   EvolutionaryTrace; P04058; -.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043083; C:synaptic cleft; IEA:GOC.
DR   GO; GO:0003990; F:acetylcholinesterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0001507; P:acetylcholine catabolic process in synaptic cleft; IEA:InterPro.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000908; Acylcholinesterase_fish/snake.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019826; Carboxylesterase_B_AS.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   InterPro; IPR000997; Cholinesterase.
DR   Pfam; PF00135; COesterase; 1.
DR   PRINTS; PR00879; ACHEFISH.
DR   PRINTS; PR00878; CHOLNESTRASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00122; CARBOXYLESTERASE_B_1; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Hydrolase; Lipoprotein; Membrane; Neurotransmitter degradation;
KW   Serine esterase; Signal; Synapse.
FT   SIGNAL        1     21       {ECO:0000269|PubMed:3900071}.
FT   CHAIN        22    564       Acetylcholinesterase.
FT                                /FTId=PRO_0000008595.
FT   PROPEP      565    586       Removed in mature form.
FT                                /FTId=PRO_0000008596.
FT   ACT_SITE    221    221       Acyl-ester intermediate.
FT   ACT_SITE    348    348       Charge relay system.
FT   ACT_SITE    461    461       Charge relay system.
FT   LIPID       564    564       GPI-anchor amidated serine.
FT                                {ECO:0000269|PubMed:8597567}.
FT   CARBOHYD     80     80       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:10368299,
FT                                ECO:0000269|PubMed:16763558}.
FT   CARBOHYD    437    437       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:10368299,
FT                                ECO:0000269|PubMed:16763558,
FT                                ECO:0000269|PubMed:1678899}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:10368299}.
FT   CARBOHYD    554    554       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:10368299}.
FT   DISULFID     88    115
FT   DISULFID    275    286
FT   DISULFID    423    542
FT   DISULFID    558    558       Interchain.
FT   VAR_SEQ     557    586       ACDGELSSSGTSSSKGIIFYVLFSILYLIF -> ETIDEAE
FT                                RQWKTEFHRWSSYMMHWKNQFDHYSRHESCAEL (in
FT                                isoform T). {ECO:0000305}.
FT                                /FTId=VSP_001460.
FT   MUTAGEN     220    220       E->H: Loss of activity.
FT                                {ECO:0000269|PubMed:2217185}.
FT   MUTAGEN     220    220       E->Q,D: Decrease in activity.
FT                                {ECO:0000269|PubMed:2217185}.
FT   MUTAGEN     221    221       S->C: Loss of activity.
FT                                {ECO:0000269|PubMed:2217185}.
FT   MUTAGEN     221    221       S->V: Loss of activity.
FT                                {ECO:0000269|PubMed:2217185}.
FT   MUTAGEN     446    446       H->Q: Almost no loss of activity.
FT                                {ECO:0000269|PubMed:2217185}.
FT   MUTAGEN     461    461       H->Q: Loss of activity.
FT                                {ECO:0000269|PubMed:2217185}.
FT   STRAND       28     31       {ECO:0000244|PDB:1EA5}.
FT   STRAND       34     37       {ECO:0000244|PDB:1EA5}.
FT   STRAND       39     43       {ECO:0000244|PDB:1EA5}.
FT   STRAND       46     55       {ECO:0000244|PDB:1EA5}.
FT   HELIX        62     64       {ECO:0000244|PDB:1EA5}.
FT   STRAND       76     80       {ECO:0000244|PDB:1EA5}.
FT   STRAND       87     89       {ECO:0000244|PDB:2CMF}.
FT   STRAND       95     98       {ECO:0000244|PDB:1OCE}.
FT   HELIX       100    103       {ECO:0000244|PDB:1EA5}.
FT   STRAND      111    113       {ECO:0000244|PDB:3ZV7}.
FT   STRAND      117    122       {ECO:0000244|PDB:1EA5}.
FT   STRAND      128    136       {ECO:0000244|PDB:1EA5}.
FT   TURN        140    142       {ECO:0000244|PDB:1EA5}.
FT   HELIX       149    151       {ECO:0000244|PDB:1EA5}.
FT   HELIX       154    160       {ECO:0000244|PDB:1EA5}.
FT   STRAND      163    166       {ECO:0000244|PDB:1EA5}.
FT   HELIX       172    176       {ECO:0000244|PDB:1EA5}.
FT   STRAND      183    185       {ECO:0000244|PDB:1EA5}.
FT   HELIX       189    204       {ECO:0000244|PDB:1EA5}.
FT   HELIX       205    208       {ECO:0000244|PDB:1EA5}.
FT   STRAND      210    220       {ECO:0000244|PDB:1EA5}.
FT   HELIX       222    232       {ECO:0000244|PDB:1EA5}.
FT   HELIX       234    237       {ECO:0000244|PDB:1EA5}.
FT   STRAND      241    247       {ECO:0000244|PDB:1EA5}.
FT   TURN        253    255       {ECO:0000244|PDB:1QID}.
FT   HELIX       259    272       {ECO:0000244|PDB:1EA5}.
FT   HELIX       280    289       {ECO:0000244|PDB:1EA5}.
FT   HELIX       292    298       {ECO:0000244|PDB:1EA5}.
FT   HELIX       299    302       {ECO:0000244|PDB:1EA5}.
FT   STRAND      304    306       {ECO:0000244|PDB:1EA5}.
FT   STRAND      319    324       {ECO:0000244|PDB:1EA5}.
FT   HELIX       326    332       {ECO:0000244|PDB:1EA5}.
FT   STRAND      340    345       {ECO:0000244|PDB:1EA5}.
FT   STRAND      347    349       {ECO:0000244|PDB:2WFZ}.
FT   HELIX       350    356       {ECO:0000244|PDB:1EA5}.
FT   STRAND      362    364       {ECO:0000244|PDB:2WG1}.
FT   HELIX       370    380       {ECO:0000244|PDB:1EA5}.
FT   HELIX       386    395       {ECO:0000244|PDB:1EA5}.
FT   TURN        399    401       {ECO:0000244|PDB:2CMF}.
FT   HELIX       405    420       {ECO:0000244|PDB:1EA5}.
FT   HELIX       422    433       {ECO:0000244|PDB:1EA5}.
FT   STRAND      435    437       {ECO:0000244|PDB:2J3Q}.
FT   STRAND      439    444       {ECO:0000244|PDB:1EA5}.
FT   HELIX       455    457       {ECO:0000244|PDB:1EA5}.
FT   TURN        461    464       {ECO:0000244|PDB:1EA5}.
FT   HELIX       465    468       {ECO:0000244|PDB:1EA5}.
FT   HELIX       471    473       {ECO:0000244|PDB:1EA5}.
FT   HELIX       475    477       {ECO:0000244|PDB:1EA5}.
FT   HELIX       481    500       {ECO:0000244|PDB:1EA5}.
FT   STRAND      501    504       {ECO:0000244|PDB:2CKM}.
FT   TURN        518    520       {ECO:0000244|PDB:1EA5}.
FT   STRAND      522    529       {ECO:0000244|PDB:1EA5}.
FT   STRAND      533    536       {ECO:0000244|PDB:1EA5}.
FT   HELIX       539    546       {ECO:0000244|PDB:1EA5}.
FT   HELIX       548    555       {ECO:0000244|PDB:1EA5}.
SQ   SEQUENCE   586 AA;  65906 MW;  731D5F0F3ABA62A8 CRC64;
     MNLLVTSSLG VLLHLVVLCQ ADDHSELLVN TKSGKVMGTR VPVLSSHISA FLGIPFAEPP
     VGNMRFRRPE PKKPWSGVWN ASTYPNNCQQ YVDEQFPGFS GSEMWNPNRE MSEDCLYLNI
     WVPSPRPKST TVMVWIYGGG FYSGSSTLDV YNGKYLAYTE EVVLVSLSYR VGAFGFLALH
     GSQEAPGNVG LLDQRMALQW VHDNIQFFGG DPKTVTIFGE SAGGASVGMH ILSPGSRDLF
     RRAILQSGSP NCPWASVSVA EGRRRAVELG RNLNCNLNSD EELIHCLREK KPQELIDVEW
     NVLPFDSIFR FSFVPVIDGE FFPTSLESML NSGNFKKTQI LLGVNKDEGS FFLLYGAPGF
     SKDSESKISR EDFMSGVKLS VPHANDLGLD AVTLQYTDWM DDNNGIKNRD GLDDIVGDHN
     VICPLMHFVN KYTKFGNGTY LYFFNHRASN LVWPEWMGVI HGYEIEFVFG LPLVKELNYT
     AEEEALSRRI MHYWATFAKT GNPNEPHSQE SKWPLFTTKE QKFIDLNTEP MKVHQRLRVQ
     MCVFWNQFLP KLLNATACDG ELSSSGTSSS KGIIFYVLFS ILYLIF
//
